170 related articles for article (PubMed ID: 8903103)
1. New therapeutic avenues in autoimmunity.
Amital H; Swissa M; Bar-Dayan Y; Buskila D; Shoenfeld Y
Res Immunol; 1996; 147(6):361-76. PubMed ID: 8903103
[TBL] [Abstract][Full Text] [Related]
2. Modulation of autoimmune responses by intravenous immunoglobulin (IVIg).
Kaveri S; Prasad N; Vassilev T; Hurez V; Pashov A; Lacroix-Desmazes S; Kazatchkine M
Mult Scler; 1997 Apr; 3(2):121-8. PubMed ID: 9291165
[TBL] [Abstract][Full Text] [Related]
3. IVIG-mediated effector functions in autoimmune and inflammatory diseases.
Galeotti C; Kaveri SV; Bayry J
Int Immunol; 2017 Dec; 29(11):491-498. PubMed ID: 28666326
[TBL] [Abstract][Full Text] [Related]
4. Dissecting the mechanism of action of intravenous immunoglobulin in human autoimmune disease: Lessons from therapeutic modalities targeting Fcγ receptors.
Shock A; Humphreys D; Nimmerjahn F
J Allergy Clin Immunol; 2020 Sep; 146(3):492-500. PubMed ID: 32721416
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of immunomodulatory action of intravenous immunoglobulin in autoimmune and systemic inflammatory diseases.
Vassilev T; Kazatchkine MD
Ther Apher; 1997 Feb; 1(1):38-41. PubMed ID: 10225779
[TBL] [Abstract][Full Text] [Related]
6. Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin.
Ahmed AR; Kaveri S
Front Immunol; 2018; 9():1189. PubMed ID: 30072982
[TBL] [Abstract][Full Text] [Related]
7. Idiotypic modulation of autoimmunity by therapeutic human immunoglobulin preparations (IVIg).
Kaveri SV; Dietrich G; Jobin D; Rossi F; Sultan Y; Lockwood CM; Kazatchkine MD
Adv Nephrol Necker Hosp; 1992; 21():329-46. PubMed ID: 1566650
[No Abstract] [Full Text] [Related]
8. Intravenous immunoglobulins in autoimmune and inflammatory diseases: a mechanistic perspective.
Sibéril S; Elluru S; Graff-Dubois S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayry J; Kaveri SV
Ann N Y Acad Sci; 2007 Sep; 1110():497-506. PubMed ID: 17911465
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin (IVIg) in the treatment of autoimmune and inflammatory diseases.
Ruiz de Souza V; Kaveri SV; Kazatchkine MD
Clin Exp Rheumatol; 1993; 11 Suppl 9():S33-6. PubMed ID: 8354005
[TBL] [Abstract][Full Text] [Related]
10. Treatment of autoimmune diseases with normal immunoglobulin through manipulation of the idiotypic network.
Ronda N; Kaveri SV; Kazatchkine MD
Clin Exp Immunol; 1993 Sep; 93 Suppl 1(Suppl 1):14-5. PubMed ID: 8365019
[No Abstract] [Full Text] [Related]
11. Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases.
Kaveri SV; Dietrich G; Hurez V; Kazatchkine MD
Clin Exp Immunol; 1991 Nov; 86(2):192-8. PubMed ID: 1934588
[TBL] [Abstract][Full Text] [Related]
12. Treatment of autoimmune diseases with intravenous gammaglobulin.
Gelfand EW
Semin Hematol; 1992 Jul; 29(3 Suppl 2):127-33. PubMed ID: 1387255
[No Abstract] [Full Text] [Related]
13. [Indications and mechanisms of action of the intravenous immunoglobulines in the systemic autoimmune and inflammatory pathologies].
Mouthon L; Bussone G; Kaveri S
Rev Med Interne; 2009 Dec; 30(12 Suppl):H14-20. PubMed ID: 19995651
[TBL] [Abstract][Full Text] [Related]
14. Indications of plasma exchanges in combination with intravenous immunoglobulins or therapeutic monoclonal antibodies. How to combine them?
Vendramin C; Scully M
Presse Med; 2019 Nov; 48(11 Pt 2):354-359. PubMed ID: 31679899
[TBL] [Abstract][Full Text] [Related]
15. [Immunomodulatory effects of intravenous immunoglobulins in autoimmune diseases].
Mouthon L; Lacroix-Desmazes S; Pashov A; Kaveri SV; Kazatchkine MD
Rev Med Interne; 1999; 20 Suppl 4():423s-430s. PubMed ID: 10522317
[TBL] [Abstract][Full Text] [Related]
16. [Use of intravenous polyclonal immunoglobulins in autoimmune and inflammatory disorders].
Graff-Dubois S; Sibéril S; Elluru S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayary J; Kaveri SV
Transfus Clin Biol; 2007 May; 14(1):63-8. PubMed ID: 17498995
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulin treatment of neurological autoimmune diseases.
Stangel M; Hartung HP; Marx P; Gold R
J Neurol Sci; 1998 Jan; 153(2):203-14. PubMed ID: 9511879
[TBL] [Abstract][Full Text] [Related]
18. Sweet SIGNs: IgG glycosylation leads the way in IVIG-mediated resolution of inflammation.
Brückner C; Lehmann C; Dudziak D; Nimmerjahn F
Int Immunol; 2017 Dec; 29(11):499-509. PubMed ID: 29300958
[TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin therapy of autoimmune and systemic inflammatory diseases.
Ronda N; Hurez V; Kazatchkine MD
Vox Sang; 1993; 64(2):65-72. PubMed ID: 8456559
[TBL] [Abstract][Full Text] [Related]
20. Modulation of autoimmunity by intravenous immune globulin through interaction with the function of the immune/idiotypic network.
Dietrich G; Kaveri SV; Kazatchkine MD
Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 2):S73-81. PubMed ID: 1728990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
